NEW NLRP3 INHIBITORS IN THE TREATMENT OF ATHEROSCLEROSIS AND HEART FAILURE WITH PRESERVED EJECTION FRACTION

Authors

  • Gaziyeva Anastasiya Ruslanovna A Third-Year Student at Kimyo International University in Tashkent, Uzbekistan, Tashkent city
  • Yusupjanova Shaxzoda Abdujalolovna A Third-Year Student at Kimyo International University in Tashkent, Uzbekistan, Tashkent City

DOI:

https://doi.org/10.17605/

Keywords:

NLRP3, inflammasome, atherosclerosis, HFpEF, inflammation

Abstract

Low-grade chronic inflammation is considered a key pathogenic mechanism underlying atherosclerosis and heart failure with preserved ejection fraction (HFpEF).

Downloads

Published

2026-05-06

Issue

Vol. 7 No. 5 (2026): Wos

Section

Articles

License

Copyright (c) 2026 Web of Scientist: International Scientific Research Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.